Some truth here.. but the forward PE is 9.2x vs 15-17-x for peers. And generics will fare much better than branded pharmaceuticals in any pricing witch hunt. Plus, Hillary is NOT going to win. Too close to Pres. Obama. Natl security will carry the day.
Nope -- canceling the preferred once. It will recoil (the mechanism) and could be sprung again.. that's why this upcoming shareholder meeting is a joke -- its not what they promised PRGO (if the deal went thru -- to get rid of the poison pill/ board governance issue. Its a technical issue of canceling the existing preferred.. a new preferred could show up the next week to scare off the next TEVA. If MYL wants a higher price (to make less dilutive purchases) it must get an M&A premium back in its stock -- that requires all this un american / stakeholder /governance issue be removed!!!!